Cysal Overview
- Founded
- 2012

- Status
- Private
- Employees
- 2

- Latest Deal Type
- Seed
- Latest Deal Amount
- $1.29M

- Investors
- 4
Cysal General Information
Description
Developer of biotechnological products designed to provide assistance in the production of dipeptides. The company's products focus on developing, optimizing and licensing microbial metabolic diversity and fermentation processes for biopolymers and low-molecular weight compounds, enabling researchers to replace chemical approaches for the production of specialty and base commodities.
Contact Information
- Mendelstraße 11
- 48149 Münster
- Germany
Cysal Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Seed Round | 08-Nov-2012 | $1.29M | 00.000 | 00.000 | Completed | Generating Revenue |
1. Grant | Completed | Generating Revenue |
Cysal Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Ahmed Sallam | Co-Founder, Chief Executive Officer and Chief Operating Officer |
Cysal Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialCysal Investors (4)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
eCAPITAL entrepreneurial Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
Gründerfonds Münsterland | Venture Capital | Minority | 000 0000 | 000000 0 | |
High-Tech Gründerfonds | Venture Capital | Minority | 000 0000 | 000000 0 | |
Federal Ministry for Economic Affairs and Energy | Limited Partner | 000 0000 | 000000 0 |